What is the next step in managing a patient with elevated DHEAS levels and a normal CBC differential?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Elevated DHEAS with Normal CBC

The next step is to perform a comprehensive hormone panel including free and total testosterone, LH, FSH, SHBG, and free androgen index, while simultaneously conducting a focused clinical assessment for signs of hyperandrogenism to differentiate between the major causes: non-classical congenital adrenal hyperplasia, PCOS, and androgen-secreting tumors. 1

Initial Hormone Panel

The diagnostic workup should include the following tests 1:

  • Free and total testosterone - essential for characterizing the androgen excess pattern
  • LH and FSH - to evaluate for PCOS (elevated LH:FSH ratio suggests PCOS)
  • SHBG and free androgen index - provides more accurate assessment of bioavailable androgens
  • Consider insulin and glucose - for metabolic assessment, particularly if PCOS is suspected 1

Critical Clinical Assessment

Signs of Hyperandrogenism to Evaluate

In prepubertal children, look for 1:

  • Early-onset body odor
  • Premature axillary or pubic hair
  • Accelerated growth velocity
  • Advanced bone age
  • Genital maturation

In postpubertal females, assess for 1:

  • Androgenetic alopecia
  • Clitoromegaly
  • Hirsutism (modified Ferriman-Gallwey score)
  • Seborrheic acne

Differential Diagnosis Based on DHEAS Level

Extremely Elevated DHEAS (>600 μg/dL or 16.3 μmol/L)

If DHEAS exceeds age-specific thresholds (>3800 ng/mL for ages 20-29, >2700 ng/mL for ages 30-39), non-classical congenital adrenal hyperplasia must be ruled out first 1. However, the positive predictive value of extremely elevated DHEAS for adrenal tumors is low 2.

  • DHEAS >600 μg/dL (16.3 μmol/L) suggests possible androgen-secreting adrenal cortical adenoma 3
  • Adrenal imaging (CT) is indicated when DHEAS is markedly elevated and testosterone is twice the upper limit of normal 3
  • The specificity of DHEAS >16.3 μmol/L for neoplasm is 98%, but sensitivity cannot be reliably calculated due to rarity 2

Moderately Elevated DHEAS with Normal or Mildly Elevated Testosterone

If testosterone is normal or mildly elevated with elevated DHEAS, the most likely diagnosis is PCOS 1, 3:

  • PCOS involves accelerated pulsatile GnRH secretion, insulin resistance, and metabolic dysregulation 1
  • Address insulin resistance, metabolic factors, and ovulatory dysfunction 1
  • SHBG is typically reduced in overweight patients, metabolic syndrome, or family history of diabetes 3

Elevated Testosterone (>2× Upper Limit Normal) with Elevated DHEAS

If testosterone exceeds twice the upper limit of normal 3:

  • Perform DHEAS assay to determine source
  • If DHEAS is normal despite elevated testosterone, consider ovarian hyperthecosis (associated with insulin resistance) or androgen-secreting ovarian tumor 3
  • Transvaginal sonography is indicated for suspected ovarian source 2

Important Clinical Pitfalls

Avoid Unnecessary Imaging

The positive predictive value of elevated testosterone (>8.7 nmol/L or 250 ng/dL) for neoplasm is only 9%, despite 98% specificity 2. Clinical evaluation alone is often sufficient screening - imaging should be reserved for:

  • Rapidly progressive virilization
  • Testosterone >8.7 nmol/L (250 ng/dL) with concerning clinical features
  • DHEAS >600 μg/dL with elevated testosterone 3, 2

Consider Rare Causes

In cases where common etiologies are excluded 4, 5:

  • Isolated functional adrenal DHEAS hypersecretion (rare, confirmed by dexamethasone suppression) 5
  • Transporter protein defects (extremely rare, associated with very high DHEAS without tumor) 4
  • Medication effects: tamoxifen, raloxifene, or Op'DDD can elevate SHBG and alter testosterone interpretation 3

Algorithmic Approach Summary

  1. Obtain hormone panel (testosterone, LH, FSH, SHBG, free androgen index) 1
  2. Assess for clinical hyperandrogenism using age-appropriate criteria 1
  3. If testosterone >2× ULN: Check DHEAS level and consider imaging based on source 3
  4. If DHEAS extremely elevated (>600 μg/dL): Rule out non-classical CAH first, then consider adrenal imaging only with concerning features 1, 3
  5. If pattern suggests PCOS: Address metabolic factors and insulin resistance 1

References

Guideline

Elevated DHEA-Sulfate: Clinical Significance and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999

Research

Recommendations for investigation of hyperandrogenism.

Annales d'endocrinologie, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.